Product Information
EPLERENONE 50 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.4504 per EA under NDC 59762110802. Its NADAC has been published 41 times since Dec 24, 2025.
FDA first approved this application on Sep 27, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the eplerenone market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762110802
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
EPLERENONEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021437FDA Approved
9/27/2002
TE Code
AB
On Market Since
11/14/2024
Pharmacological Classes
Price Statistics
The NADAC for EPLERENONE 50 MG TABLET has been published 41 times since Dec 24, 2025, and over the history we have for it it has declined 9.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4504 per EA |
|---|---|
| All-time high | $0.4967 (Jan 14, 2026) |
| All-time low | $0.4504 (Sep 23, 2026) |
| 52-week high | $0.4967 |
| 52-week low | $0.4504 |
| Median price | $0.4637 |
| Average price | $0.4658 |
| Largest weekly change | -6.7% (Jan 21, 2026) |
| Weeks tracked | 41 |
| Tracking since | Dec 24, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
eplerenone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aldosterone Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of EPLERENONE 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for EPLERENONE 50 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.4504 per EA (NDC 59762110802), effective Sep 30, 2026.
How has the price of EPLERENONE 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for EPLERENONE 50 MG TABLET has declined 9.3%. It has been tracked across 41 weekly CMS publications since Dec 24, 2025.
What are the highest and lowest recorded NADAC prices for EPLERENONE 50 MG TABLET?
Since Dec 24, 2025, the NADAC for EPLERENONE 50 MG TABLET has ranged from a low of $0.4504 (Sep 23, 2026) to a high of $0.4967 (Jan 14, 2026), with a median of $0.4637 per EA.
Are there cheaper alternatives to EPLERENONE 50 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as EPLERENONE 50 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures EPLERENONE 50 MG TABLET?
EPLERENONE 50 MG TABLET (NDC 59762110802) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.